Literature DB >> 20811558

Surgical options for drug-refractory overactive bladder patients.

Jonathan S Starkman, Christopher P Smith, David R Staskin.   

Abstract

Overactive bladder (OAB) is a symptom complex of urinary frequency, urinary urgency, and nocturia, with or without urgency incontinence. This syndrome is idiopathic in most instances without clearly defined pathophysiology. Studies clearly show that OAB negatively impacts health-related quality of life and impairs daily functioning in a large proportion of patients. Despite recent advances in drug delivery and improved tolerability of antimuscarinic drug class, a large percentage of patients remain refractory to conventional pharmacological therapy for this chronic condition. There are several unique and effective treatments that are available for this difficult population. We review the various surgical options within the urological armamentarium to treat patients with refractory OAB.

Entities:  

Keywords:  Botulinum neurotoxins; Muscarinic receptor-blocking agents; Overactive bladder syndrome; Posterior tibial nerve stimulation; Sacral neuromodulation; Urinary urgency incontinence

Year:  2010        PMID: 20811558      PMCID: PMC2931287     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  44 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Authors:  D M Schmid; P Sauermann; M Werner; B Schuessler; N Blick; M Muentener; R T Strebel; D Perucchini; D Scheiner; G Schaer; H John; A Reitz; D Hauri; B Schurch
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

Review 3.  How sacral nerve stimulation neuromodulation works.

Authors:  Wendy W Leng; Michael B Chancellor
Journal:  Urol Clin North Am       Date:  2005-02       Impact factor: 2.241

Review 4.  Electrical stimulation in the clinical management of the neurogenic bladder.

Authors:  E A Tanagho; R A Schmidt
Journal:  J Urol       Date:  1988-12       Impact factor: 7.450

5.  Functional evaluation of sacral nerve root integrity. Report of a technique.

Authors:  R A Schmidt; E Senn; E A Tanagho
Journal:  Urology       Date:  1990-05       Impact factor: 2.649

6.  Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?

Authors:  Thomas M Kessler; Helmut Madersbacher; Gustav Kiss
Journal:  Eur Urol       Date:  2005-01-04       Impact factor: 20.096

7.  Medium-term experience of sacral neuromodulation by tined lead implantation.

Authors:  Anco C Van Voskuilen; Dennis J A J Oerlemans; Ernest H J Weil; Ubi van den Hombergh; Philip E V A van Kerrebroeck
Journal:  BJU Int       Date:  2006-09-06       Impact factor: 5.588

8.  A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation.

Authors:  K Everaert; W Kerckhaert; H Caluwaerts; M Audenaert; H Vereecke; G De Cuypere; A Boelaert; U Van den Hombergh; W Oosterlinck
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

9.  Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.

Authors:  Arun Sahai; Christopher Dowson; Mohammad S Khan; Prokar Dasgupta
Journal:  BJU Int       Date:  2009-04-15       Impact factor: 5.588

10.  New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results.

Authors:  Michele Spinelli; Gianluca Giardiello; Andrea Arduini; Ubi van den Hombergh
Journal:  Eur Urol       Date:  2003-01       Impact factor: 20.096

View more
  4 in total

Review 1.  Management of OAB in those over age 65.

Authors:  Ricardo Natalin; Fabio Lorenzetti; Miriam Dambros
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Non-invasive evaluation of botulinum-A toxin treatment efficacy in children with refractory overactive bladder.

Authors:  Murat Uçar; Ahsen Karagözlü Akgül; Ayşe Parlak; Cem Yücel; Nizamettin Kılıç; Emin Balkan
Journal:  Int Urol Nephrol       Date:  2018-07-02       Impact factor: 2.370

Review 3.  From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).

Authors:  Susanne Deininger; Peter Törzsök; Michael Mitterberger; Maximilian Pallauf; David Oswald; Christian Deininger; Lukas Lusuardi
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

4.  OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single-dose treatment from a phase III, randomized, double-blind, placebo-controlled trial (interim analysis).

Authors:  Osamu Yokoyama; Masashi Honda; Tomonori Yamanishi; Yuki Sekiguchi; Kenji Fujii; Takashi Nakayama; Takao Mogi
Journal:  Int J Urol       Date:  2020-01-20       Impact factor: 3.369

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.